CoChat
Sign Up
Cited by 28

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Reviewing the biological activity of chitosan in the mucosa: Focus on intestinal immunity

Moine, L., Canali, M.M., Porporatto, C., Correa, S.G.·2021·International Journal of Biological Macromolecules
DOI 10.1016/j.ijbiomac.2021.08.098
Open this paper in CoChat — free account

Abstract

Chitosan is a polymer derived from the partial deacetylation of chitin with particular characteristics, such as mucoadhesiveness, tolerability, biocompatibility and biodegradability. Biomedical uses of chitosan cover a wide spectrum of applications as dietary fiber, immunoadjuvant and regulator of the intestinal microbiota or delivery agent. Chemical modification of chitosan is feasible because its reactive amino and hydroxyl groups can be modified by a diverse array of ligands, functional groups and molecules. This gives rise to numerous derivatives that allow different formulation types influencing their activity. Considering the multiple events resulting from the interaction with mucosal tissues, chitosan is a singular candidate for strategies targeting immune stimulation (i.e., tolerance induction, vaccination). Its role as a prebiotic and probiotic carrier represents an effective option to manage intestinal dysbiosis. In the intestinal scenario where the exposure of the immune system to a wide variety of antigens is permanent, chitosan increases IgA levels and favors a tolerogenic environment, thus becoming a key ally for host homeostasis.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.ijbiomac.2021.08.098

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 114

  1. Torres, 2019, Natural polysaccharide nanomaterials: an overview of their immunological properties, Int. J. Mol. Sci., 20, 5092, 10.3390/ijms20205092 · DOI
  2. Faria, 2016, Computational study of polymorphic structures of a- and ß- chitin and chitosan in aqueous solution, J. Mol. Graph. Model., 63, 78, 10.1016/j.jmgm.2015.11.001 · DOI
  3. Younes, 2015, Chitin and chitosan preparation from marine sources. structure, properties and applications, Mar. Drugs, 13, 1133, 10.3390/md13031133 · DOI
  4. Pomin, 2009, Review: an overview about the structure-function relationship of marine sulfated homopolysaccharides with regular chemical structures, Biopolymers, 91, 601, 10.1002/bip.21200 · DOI
  5. Pomin, 2014, Marine medicinal glycomics, Front. Cell. Infect. Microbiol., 4, 2014
  6. Liu, 2018, Synthesis, characterization and antifungal efficacy of chitosan derivatives with triple quaternary ammonium groups, Int. J. Biol. Macromol., 114, 942, 10.1016/j.ijbiomac.2018.03.179 · DOI
  7. Yu, 2019, Preparation, characterization, and antibacterial properties of biofilms comprising chitosan and e-polylysine, Int. J. Biol. Macromol., 141, 545, 10.1016/j.ijbiomac.2019.09.035 · DOI
  8. Chi, 2019, Antitumor evaluation of carboxymethyl chitosan based norcantharidin conjugates against gastric cancer as novel polymer therapeutics, Int. J. Biol. Macromol., 136, 1, 10.1016/j.ijbiomac.2019.05.216 · DOI
  9. Zhang, 2018, Synthesis, characterization, and the antioxidant activity of N, N, N-trimethyl chitosan salts, Int. J. Biol. Macromol., 118, 9, 10.1016/j.ijbiomac.2018.06.018 · DOI
  10. Lütjohann, 2018, Influence of chitosan treatment on surrogate serum markers of cholesterol metabolism in obese subjects, Nutrients, 10, 72, 10.3390/nu10010072 · DOI
  11. Sun, 2018, Polysaccharides as vaccine adjuvants, Vaccine, 36, 5226, 10.1016/j.vaccine.2018.07.040 · DOI
  12. Khoushab, 2010, Chitin research revisited, Mar. Drugs, 8, 1988, 10.3390/md8071988 · DOI
  13. Periayah, 2016, Chitosan: a promising marine polysaccharide for biomedical research, Pharmacogn. Rev., 10, 39, 10.4103/0973-7847.176545 · DOI
  14. Crini, 2019, Historical review on chitin and chitosan biopolymers, Environ. Chem. Lett., 17, 1623, 10.1007/s10311-019-00901-0 · DOI
  15. Darmon, 1950, Infrared and X-ray studies of chitin, Discuss. Faraday Soc., 9, 251, 10.1039/df9500900251 · DOI
  16. Araki, 1975, A pathway of chitosan formation in Mucor rouxii: enzymatic deacetylation of chitin, Biochem. Biophys. Res. Commun., 56, 669, 10.1016/0006-291X(74)90657-3 · DOI
  17. Hirano, 1976, Selective N-acylation of chitosan, Carbohyd. Res., 47, 315, 10.1016/S0008-6215(00)84198-1 · DOI
  18. Kendra, 1984, Characterization of the smallest chitosan oligomer that is maximally antifungal to fusarium solani and elicits pisatin formation in Pisum sativum, Exp. Mycol., 8, 276, 10.1016/0147-5975(84)90013-6 · DOI · Paper page
  19. Bodmeier, 1989, A novel approach to the oral delivery of micro- or nanoparticles, Pharm. Res., 6, 413, 10.1023/A:1015987516796 · DOI
  20. Hassan, 1992, Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole, Pharm. Res., 9, 390, 10.1023/A:1015803321609 · DOI
  21. Hayatsu, 2000, Pigment molecules linked to polymer support: blue rayon, blue chitin, and green chitosan-synthesis and applications, Yakugaku Zasshi, 120, 534, 10.1248/yakushi1947.120.6_534 · DOI
  22. Hatta, 1950, Studies on macramin, a new high-molecular antibacterial substance derived from chitin, Jpn. Med. J. (Natl. Inst. Health Jpn.)., 3, 119
  23. Reber, 1959, Dose-response relations of N-formyl-chitosan-polysulfuric acid ester (Ro 1–8307) in regard to the activation of the clearing factor & inhibition of coagulation in comparison with heparin in animal experiments & in man, Acta Haematol., 21, 31, 10.1159/000205654 · DOI
  24. Muzzarelli, 1969, Chitin and chitosan as chromatographic supports and adsorbents for collection of metal ions from organic and aqueous solutions and sea-water, Talanta, 16, 1571, 10.1016/0039-9140(69)80218-3 · DOI
  25. Whistler, 1971, Anticoagulant activity of oxidized and N- and O-sulfated chitosan, Arch. Biochem. Biophys., 142, 106, 10.1016/0003-9861(71)90264-5 · DOI
  26. Hadwiger, 1980, Chitosan as a component of pea-fusarium solani interactions, Plant Physiol., 66, 205, 10.1104/pp.66.2.205 · DOI
  27. Young, 1982, Effect of chitosan on membrane permeability of suspension-cultured glycine max and phaseolus vulgaris cells, Plant Physiol., 70, 1449, 10.1104/pp.70.5.1449 · DOI
  28. Sapozhnikov, 1984, Effect of chitosan on the electrophoretic motility of thymocytes, Biofizika, 29, 272
  29. Lee, 2002, Chitosan oligosaccharides, dp 2–8, have prebiotic effect on the bifidobacterium bifidium and lactobacillus sp, Anaerobe, 8, 319, 10.1016/S1075-9964(03)00030-1 · DOI
  30. Allan, 1979, The fungicidal effect of chitosan on fungi of varying cell wall composition, Exp. Mycol., 3, 285, 10.1016/S0147-5975(79)80054-7 · DOI
  31. Sugano, 1980, A novel use of chitosan as a hypocholesterolemic agent in rats, Am. J. Clin. Nutr., 33, 787, 10.1093/ajcn/33.4.787 · DOI
  32. Miyazaki, 1981, The use of chitin and chitosan as drug carriers, Chem. Pharm. Bull., 29, 3067, 10.1248/cpb.29.3067 · DOI
  33. Ishihara, 1993, Anti-viral activity of sulfated chitin derivatives against friend murine leukaemia and herpes simplex type-1 viruses, Vaccine, 11, 670, 10.1016/0264-410X(93)90315-O · DOI
  34. Ouyang, 2017, Application of chitosan, chitooligosaccharide, and their derivatives in the treatment of Alzheimer's disease, Mar. Drugs, 15, 322, 10.3390/md15110322 · DOI
  35. Tatlow, 2020, A novel concept for treatment and vaccination against Covid-19 with an inhaled chitosan-coated DNA vaccine encoding a secreted spike protein portion, Clin. Exp. Pharmacol. Physiol., 47, 1874, 10.1111/1440-1681.13393 · DOI
  36. Bartone, 1988, Chitosan: effects on wound healing in urogenital tissue: preliminary report, J. Urol., 140, 1134, 10.1016/S0022-5347(17)41980-X · DOI
  37. Muzzarelli, 1989, Reconstruction of parodontal tissue with chitosan, Biomaterials, 10, 598, 10.1016/0142-9612(89)90113-0 · DOI
  38. Shahabeddin, 1990, Characterization of skin reconstructed on a chitosan-cross-linked collagen-glycosaminoglycan matrix, Skin Pharmacol., 3, 107, 10.1159/000210857 · DOI
  39. Muzzarelli, 1994, Stimulatory effect on bone formation exerted by a modified chitosan, Biomaterials, 15, 1075, 10.1016/0142-9612(94)90093-0 · DOI · Paper page
  40. Wang, 2020, Chitosan derivatives and their application in biomedicine, Int. J. Mol. Sci., 21, 487, 10.3390/ijms21020487 · DOI
  41. Shariatinia, 2018, Carboxymethyl chitosan: properties and biomedical applications, Int. J. Biol. Macromol., 120, 1406, 10.1016/j.ijbiomac.2018.09.131 · DOI · Paper page
  42. Mourya, 2010, Carboxymethyl chitosan and its applications, Adv. Mat. Lett., 1, 11, 10.5185/amlett.2010.3108 · DOI
  43. Elgadir, 2015, Impact of chitosan composites and chitosan nanoparticle composites on various drug delivery systems: a review, J. Food Drug Anal., 23, 619, 10.1016/j.jfda.2014.10.008 · DOI
  44. Singh, 2018, Needle-free immunization with chitosan-based systems, Int. J. Mol. Sci., 19, 3639, 10.3390/ijms19113639 · DOI
  45. Nechaeva, 2002, Development of oral microencapsulated forms for delivering viral vaccines, Expert Rev. Vaccines, 1, 385, 10.1586/14760584.1.3.385 · DOI
  46. Vanden Braber, 2018, Controlled release and antioxidant activity of chitosan or its glucosamine water-soluble derivative microcapsules loaded with quercetin, Int. J. Biol. Macromol., 112, 399, 10.1016/j.ijbiomac.2018.01.085 · DOI
  47. Du, 2008, Preparation, characterization and antibacterial properties against E. coli K(88) of chitosan nanoparticle loaded copper ions, Nanotechnology, 19, 10.1088/0957-4484/19/8/085707 · DOI
  48. Orellano, 2019, Chitosan nanoparticles enhance the antibacterial activity of the native polymer against bovine mastitis pathogens, Carbohydr. Polym., 213, 1, 10.1016/j.carbpol.2019.02.016 · DOI
  49. Qi, 2007, In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles, Eur. J. Cancer, 43, 184, 10.1016/j.ejca.2006.08.029 · DOI
  50. Dumkliang, 2021, Feasibility of chitosan-based nanoparticles approach for intranasal immunisation of live attenuated japanese encephalitis vaccine, Int. J. Biol. Macromol., 183, 1096, 10.1016/j.ijbiomac.2021.05.050 · DOI
  51. Vanden Braber, 2018, Soy genistein administered in soluble chitosan microcapsules maintains antioxidant activity and limits intestinal inflammation, J. Nutr. Biochem., 62, 50, 10.1016/j.jnutbio.2018.08.009 · DOI
  52. Venter, 2006, Synthesis and evaluation of the mucoadhesivity of a CD-chitosan derivative, Int. J. Pharm., 313, 36, 10.1016/j.ijpharm.2006.01.016 · DOI
  53. Vllasaliu, 2010, Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution, Int. J. Pharmacol., 400, 183, 10.1016/j.ijpharm.2010.08.020 · DOI
  54. Kootala, 2018, Reinforcing mucus barrier properties with low molar mass chitosans, Biomacromolecules, 19, 872, 10.1021/acs.biomac.7b01670 · DOI
  55. Sandri, 2006, Histological evaluation of buccal penetration enhancement properties of chitosan and trimethyl chitosan, J. Pharm. Pharmacol., 58, 1327, 10.1211/jpp.58.10.0005 · DOI
  56. Jin, 2015, Buccal mucosal delivery of a potent peptide leads to therapeutically-relevant plasma concentrations for the treatment of autoimmune diseases, J. Control. Release, 199, 37, 10.1016/j.jconrel.2014.12.001 · DOI
  57. Saeed, 2015, Development of enhanced antibody response toward dual delivery of nano-adjuvant adsorbed human Enterovirus-71 vaccine encapsulated carrier, Hum. Vaccin. Immunother., 11, 2414, 10.1080/21645515.2015.1052918 · DOI
  58. Wu, 2012, Novel thermal-sensitive hydrogel enhances both humoral and cell-mediated immune responses by intranasal vaccine delivery, Eur. J. Pharm. Biopharm., 81, 486, 10.1016/j.ejpb.2012.03.021 · DOI
  59. Smith, 2004, Effect of chitosan on epithelial cell tight junctions, Pharm. Res., 21, 43, 10.1023/B:PHAM.0000012150.60180.e3 · DOI
  60. Canali, 2012, Chitosan enhances transcellular permeability in human and rat intestine epithelium, Eur. J. Pharm. Biopharm., 80, 418, 10.1016/j.ejpb.2011.11.007 · DOI
  61. Benediktsdóttir, 2014, Challenges in evaluation of chitosan and trimethylated chitosan (TMC) as mucosal permeation enhancers: from synthesis to in vitro application, J. Control. Release, 173, 18, 10.1016/j.jconrel.2013.10.022 · DOI
  62. Hagesaether, 2011, Permeation modulating properties of natural polymers effect of molecular weight and mucus, Int. J. Pharm., 409, 150, 10.1016/j.ijpharm.2011.02.046 · DOI
  63. Zhang, 2014, Mechanism study of cellular uptake and tight junction opening mediated by goblet cell-specific trimethyl chitosan nanoparticles, Mol. Pharm., 11, 1520, 10.1021/mp400685v · DOI
  64. Slütter, 2009, Mechanistic study of the adjuvant effect of biodegradable nanoparticles in mucosal vaccination, J. Control. Release, 138, 113, 10.1016/j.jconrel.2009.05.011 · DOI
  65. Chen, 2018, Targeted delivery of antigen to intestinal dendritic cells induces oral tolerance and prevents autoimmune diabetes in NOD mice, Diabetologia, 61, 1384, 10.1007/s00125-018-4593-3 · DOI
  66. Canali, 2010, Signals elicited at the intestinal epithelium upon chitosan feeding contribute to immunomodulatory activity and biocompatibility of the polysaccharide, Vaccine, 28, 5718, 10.1016/j.vaccine.2010.06.027 · DOI
  67. Shang, 2017, Characterization of fecal fat composition and gut derived fecal microbiota in high-fat diet fed rats following intervention with chito-oligosaccharide and resistant starch complexes, Food Funct., 8, 4374, 10.1039/C7FO01244F · DOI
  68. McDole, 2012, Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine, Nature, 483, 345, 10.1038/nature10863 · DOI
  69. Jin, 2012, Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport, Biomaterials, 33, 1573, 10.1016/j.biomaterials.2011.10.075 · DOI · Paper page
  70. Blanchard, 2004, IL-4 and IL-13 upregulate intestinal trefoil factor expression: requirement for STAT6 and de novo protein synthesis, J. Immunol., 172, 3775, 10.4049/jimmunol.172.6.3775 · DOI
  71. Abdel-Latif, 2016, Anticoccidial activities of chitosan on eimeria papillata-infected mice, Parasitol. Res., 115, 2845, 10.1007/s00436-016-5035-0 · DOI
  72. Kulkarni, 2020, Goblet cell associated antigen passages support the induction and maintenance of oral tolerance, Mucosal Immunol., 13, 271, 10.1038/s41385-019-0240-7 · DOI
  73. Koppolu, 2013, The effect of antigen encapsulation in chitosan particles on uptake, activation and presentation by antigen presenting cells, Biomaterials, 34, 2359, 10.1016/j.biomaterials.2012.11.066 · DOI
  74. Fong, 2017, Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages, Biomaterials, 129, 127, 10.1016/j.biomaterials.2017.03.022 · DOI
  75. Carroll, 2016, The vaccine adjuvant chitosan promotes cellular immunity via DNA sensor cGAS-STING-dependent induction of type I interferons, Immunity, 44, 597, 10.1016/j.immuni.2016.02.004 · DOI
  76. Bueter, 2014, Spectrum and mechanisms of inflammasome activation by chitosan, J. Immunol., 192, 5943, 10.4049/jimmunol.1301695 · DOI
  77. Da Silva, 2008, TLR-2 and IL-17A in chitin-induced macrophage activation and acute inflammation, J. Immunol., 181, 4279, 10.4049/jimmunol.181.6.4279 · DOI
  78. Powell, 2015, Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes, Clin. Exp. Vaccine Res., 4, 23, 10.7774/cevr.2015.4.1.23 · DOI
  79. Feng, 2004, Receptor-mediated stimulatory effect of oligochitosan in macrophages, Biochem. Biophys. Res. Commun., 317, 414, 10.1016/j.bbrc.2004.03.048 · DOI
  80. Martinez-Pomares, 2012, The mannose receptor, J. Leukoc. Biol., 92, 1177, 10.1189/jlb.0512231 · DOI
  81. Hoemann, 2013, Chitosan rate of uptake in HEK293 cells is influenced by soluble versus microparticle state and enhanced by serum-induced cell metabolism and lactate-based media acidification, Molecules, 18, 1015, 10.3390/molecules18011015 · DOI
  82. Porporatto, 2005, Local and systemic activity of the polysaccharide chitosan at lymphoid tissues after oral administration, J. Leukoc. Biol., 78, 62, 10.1189/jlb.0904541 · DOI
  83. Zhao, 2018, Mesenteric CD103 DCs initiate switched coxsackievirus B3 VP1-specific IgA response to intranasal chitosan-DNA vaccine through secreting BAFF/IL-6 and promoting Th17/Tfh differentiation, Front. Immunol., 9, 2986, 10.3389/fimmu.2018.02986 · DOI
  84. Fong, 2015, Biodegradable chitosan microparticles induce delayed STAT-1 activation and lead to distinct cytokine responses in differentially polarized human macrophages in vitro, Acta Biomater., 12, 183, 10.1016/j.actbio.2014.10.026 · DOI
  85. Vasconcelos, 2019, 3D chitosan scaffolds impair NLRP3 inflammasome response in macrophages, Acta Biomater., 91, 123, 10.1016/j.actbio.2019.04.035 · DOI
  86. Vasconcelos, 2013, Macrophage polarization following chitosan implantation, Biomaterials, 34, 9952, 10.1016/j.biomaterials.2013.09.012 · DOI
  87. Deng, 2019, A molecular targeted immunotherapeutic strategy for ulcerative colitis via dual-targeting nanoparticles delivering miR-146b to intestinal macrophages, J. Crohns Colitis, 13, 482, 10.1093/ecco-jcc/jjy181 · DOI
  88. Cao, 2020, IGF-1C hydrogel improves the therapeutic effects of MSCs on colitis in mice through PGE2-mediated M2 macrophage polarization, Theranostics, 10, 7697, 10.7150/thno.45434 · DOI
  89. Porporatto, 2004, Early events associated to the oral co-administration of type II collagen and chitosan: induction of anti-inflammatory cytokines, Int. Immunol., 16, 433, 10.1093/intimm/dxh051 · DOI
  90. Brand, 2002, Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model, J. Immunol., 168, 490, 10.4049/jimmunol.168.1.490 · DOI
  91. Shi, 2000, Enteric infection acts as an adjuvant for the response to a model food antigen, J. Immunol., 165, 6174, 10.4049/jimmunol.165.11.6174 · DOI
  92. Porporatto, 2009, Ability of the polysaccharide chitosan to inhibit proliferation of CD4+ lymphocytes from mucosal inductive sites, in vitro and in vivo, Cell Prolif., 42, 780, 10.1111/j.1365-2184.2009.00634.x · DOI
  93. Porporatto, 2009, The biocompatible polysaccharide chitosan enhances the oral tolerance to type II collagen, Clin. Exp. Immunol., 155, 79, 10.1111/j.1365-2249.2008.03777.x · DOI
  94. Hyun, 2017, Succinylated chitosan derivative has local protective effects on intestinal inflammation, ACS Biomater. Sci. Eng., 3, 1853, 10.1021/acsbiomaterials.7b00262 · DOI
  95. Su, 2016, Induction of mucosal immunity through systemic immunization: phantom or reality?, Hum. Vaccin. Immunother., 12, 1070, 10.1080/21645515.2015.1114195 · DOI
  96. Lim, 1997, Dietary fibers modulate indices of intestinal immune function in rats, J. Nutr., 127, 663, 10.1093/jn/127.5.663 · DOI
  97. Xu, 2020, Effects of chitosan nanoparticle supplementation on growth performance, humoral immunity, gut microbiota and immune responses after lipopolysaccharide challenge in weaned pigs, J. Anim. Physiol. Anim. Nutr., 104, 597, 10.1111/jpn.13283 · DOI
  98. Kobayashi, 2013, Evaluation of the effectiveness and safety of chitosan derivatives as adjuvants for intranasal vaccines, Viral Immunol., 26, 133, 10.1089/vim.2012.0057 · DOI
  99. Zheng, 2018, Chitosan oligosaccharides improve the disturbance in glucose metabolism and reverse the dysbiosis of gut microbiota in diabetic mice, Carbohydr. Polym., 190, 77, 10.1016/j.carbpol.2018.02.058 · DOI
  100. Altamimi, 2016, Effect of oligosaccharides on the adhesion of gut bacteria to human HT-29 cells, Anaerobe, 39, 136, 10.1016/j.anaerobe.2016.03.010 · DOI
  101. Guan, 2016, Dietary chitosan supplementation increases microbial diversity and attenuates the severity of Citrobacter rodentium infection in mice, Mediat. Inflamm., 10.1155/2016/9236196 · DOI
  102. Zou, 2016, Advances in characterisation and biological activities of chitosan and chitosan oligosaccharides, Food Chem., 190, 1174, 10.1016/j.foodchem.2015.06.076 · DOI
  103. Egan, 2015, Prawn Shell chitosan has anti-obesogenic properties, influencing both nutrient digestibility and microbial populations in a pig model, PLoS One, 10, 10.1371/journal.pone.0144127 · DOI
  104. Chang, 2014, The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition, Proc. Natl. Acad. Sci. U. S. A., 111, 2247, 10.1073/pnas.1322269111 · DOI · Paper page
  105. Porporatto, 2003, Chitosan induces different L-arginine metabolic pathways in resting and inflammatory macrophages, Biochem. Biophys. Res. Commun., 304, 266, 10.1016/S0006-291X(03)00579-5 · DOI
  106. Wu, 2021, Chitosan alleviated menopausal symptoms and modulated the gut microbiota in estrogen-deficient rats, Eur. J. Nutr., 60, 1907, 10.1007/s00394-020-02382-2 · DOI
  107. Hou, 2003, Increase of viability of entrapped cells of lactobacillus delbrueckii ssp. bulgaricus in artificial sesame oil emulsions, J. Dairy Sci., 86, 424, 10.3168/jds.S0022-0302(03)73620-0 · DOI
  108. Ramos, 2018, Physiological protection of probiotic microcapsules by coatings, Crit. Rev. Food Sci. Nutr., 58, 1864, 10.1080/10408398.2017.1289148 · DOI
  109. Cook, 2011, Production and evaluation of dry alginate-chitosan microcapsules as an enteric delivery vehicle for probiotic bacteria, Biomacromolecules, 12, 2834, 10.1021/bm200576h · DOI
  110. Bepeyeva, 2017, Encapsulation of lactobacillus casei into calcium pectinate-chitosan beads for enteric delivery, J. Food Sci., 82, 2954, 10.1111/1750-3841.13974 · DOI
  111. Rodklongtan, 2014, Enhancement of lactobacillus reuteri KUB-AC5 survival in broiler gastrointestinal tract by microencapsulation with alginate-chitosan semi-interpenetrating polymer networks, J. Appl. Microbiol., 117, 227, 10.1111/jam.12517 · DOI
  112. Lohrasbi, 2020, The effect of improved formulation of chitosan-alginate microcapsules of bifidobacteria on serum lipid profiles in mice, Microb. Pathog., 149, 10.1016/j.micpath.2020.104585 · DOI
  113. Cheow, 2014, Controlled release of lactobacillus rhamnosus biofilm probiotics fromalginate-locust bean gum microcapsules, Carbohydr. Polym., 103, 587, 10.1016/j.carbpol.2014.01.036 · DOI
  114. Cook, 2012, Microencapsulation of probiotics for gastrointestinal delivery, J. Control. Release, 162, 56, 10.1016/j.jconrel.2012.06.003 · DOI

Cited by

Sorted by citations

See all 28

Metadata

Authors
Moine, L., Canali, M. M., Porporatto, C., & Correa, S. G.
Venue
International Journal of Biological Macromolecules
Publisher
Elsevier BV
Published
2021-10
Volume
189
Pages
324-334
ISSN
0141-8130
DOI
10.1016/j.ijbiomac.2021.08.098
Cited by
28
References
2
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review